No abstract available
MeSH terms
-
Chemotherapy, Adjuvant* / economics
-
Chemotherapy, Adjuvant* / statistics & numerical data
-
Controlled Clinical Trials as Topic / statistics & numerical data
-
Cost-Benefit Analysis
-
Disease-Free Survival
-
Follow-Up Studies
-
Humans
-
Immunologic Factors / administration & dosage
-
Immunologic Factors / economics
-
Immunologic Factors / therapeutic use*
-
Interferon alpha-2
-
Interferon-alpha / administration & dosage
-
Interferon-alpha / economics
-
Interferon-alpha / therapeutic use*
-
Lymphatic Metastasis
-
Melanoma / drug therapy*
-
Melanoma / immunology
-
Melanoma / pathology
-
Melanoma / secondary
-
Meta-Analysis as Topic
-
Multicenter Studies as Topic / statistics & numerical data
-
Neoplasm Staging
-
Recombinant Proteins
-
Risk
-
Survival Analysis
-
Treatment Outcome
Substances
-
Immunologic Factors
-
Interferon alpha-2
-
Interferon-alpha
-
Recombinant Proteins